Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

The inflammation-nutrition score supports the prognostic prediction of the TNM stage for colorectal cancer patients after curative resection.

Fujino S, Myoshi N, Saso K, Sasaki M, Ishikawa S, Takahashi Y, Yasui M, Ohue M, Hata T, Matsuda C, Mizushima T, Mori M, Doki Y.

Surg Today. 2019 Aug 14. doi: 10.1007/s00595-019-01861-2. [Epub ahead of print]

PMID:
31414182
2.

Erratum: A novel prognostic prediction model for recurrence in patients with stage II colon cancer after curative resection.

Saso K, Myoshi N, Fujino S, Takenaka Y, Takahashi Y, Nishimura J, Yasui M, Ohue M, Tokuoka M, Ide Y, Takahashi H, Haraguchi N, Hata T, Matsuda C, Mizushima T, Doki Y, Mori M.

Mol Clin Oncol. 2019 Aug;11(2):213. doi: 10.3892/mco.2019.1879. Epub 2019 Jun 13.

3.

Chaperones of the class I peptide-loading complex facilitate the constitutive presentation of endogenous antigens on HLA-DP84GGPM87.

Anczurowski M, Sugata K, Matsunaga Y, Yamashita Y, Wang CH, Guo T, Murata K, Saijo H, Kagoya Y, Saso K, Butler MO, Hirano N.

J Autoimmun. 2019 Aug;102:114-125. doi: 10.1016/j.jaut.2019.04.023. Epub 2019 May 8.

PMID:
31078377
4.

New marking method involving a light-emitting diode and power source device to localize gastrointestinal cancer in laparoscopic surgery.

Wada Y, Miyoshi N, Fujino S, Ohue M, Yasui M, Takahashi Y, Takahashi H, Nishimura J, Takenaka Y, Saso K, Tomokuni A, Sugimura K, Akita H, Takahashi H, Kobayashi S, Omori T, Miyata H, Yano M.

Sci Rep. 2019 Apr 2;9(1):5485. doi: 10.1038/s41598-019-41981-w.

5.

A novel prognostic prediction model for recurrence in patients with stage II colon cancer after curative resection.

Saso K, Myoshi N, Fujino S, Takenaka Y, Takahashi Y, Nishimura J, Yasui M, Ohue M, Tokuoka M, Ide Y, Takahashi H, Haraguchi N, Hata T, Matsuda C, Mizushima T, Doki Y, Mori M.

Mol Clin Oncol. 2018 Dec;9(6):697-701. doi: 10.3892/mco.2018.1733. Epub 2018 Oct 4. Erratum in: Mol Clin Oncol. 2019 Aug;11(2):213.

6.

Arginine methylation of FOXP3 is crucial for the suppressive function of regulatory T cells.

Kagoya Y, Saijo H, Matsunaga Y, Guo T, Saso K, Anczurowski M, Wang CH, Sugata K, Murata K, Butler MO, Arrowsmith CH, Hirano N.

J Autoimmun. 2019 Feb;97:10-21. doi: 10.1016/j.jaut.2018.09.011. Epub 2018 Oct 11.

PMID:
30318155
7.

JMJD2B/KDM4B inactivation in adipose tissues accelerates obesity and systemic metabolic abnormalities.

Kang C, Saso K, Ota K, Kawazu M, Ueda T, Okada H.

Genes Cells. 2018 Sep;23(9):767-777. doi: 10.1111/gtc.12627. Epub 2018 Aug 2.

8.

DOT1L inhibition attenuates graft-versus-host disease by allogeneic T cells in adoptive immunotherapy models.

Kagoya Y, Nakatsugawa M, Saso K, Guo T, Anczurowski M, Wang CH, Butler MO, Arrowsmith CH, Hirano N.

Nat Commun. 2018 May 15;9(1):1915. doi: 10.1038/s41467-018-04262-0.

9.

Mechanisms underlying the lack of endogenous processing and CLIP-mediated binding of the invariant chain by HLA-DP84Gly.

Anczurowski M, Yamashita Y, Nakatsugawa M, Ochi T, Kagoya Y, Guo T, Wang CH, Rahman MA, Saso K, Butler MO, Hirano N.

Sci Rep. 2018 Mar 19;8(1):4804. doi: 10.1038/s41598-018-22931-4.

10.

A novel chimeric antigen receptor containing a JAK-STAT signaling domain mediates superior antitumor effects.

Kagoya Y, Tanaka S, Guo T, Anczurowski M, Wang CH, Saso K, Butler MO, Minden MD, Hirano N.

Nat Med. 2018 Mar;24(3):352-359. doi: 10.1038/nm.4478. Epub 2018 Feb 5.

11.

A Subset of Human Autoreactive CD1c-Restricted T Cells Preferentially Expresses TRBV4-1+ TCRs.

Guo T, Koo MY, Kagoya Y, Anczurowski M, Wang CH, Saso K, Butler MO, Hirano N.

J Immunol. 2018 Jan 15;200(2):500-511. doi: 10.4049/jimmunol.1700677. Epub 2017 Dec 13.

12.

HLA-DP84Gly constitutively presents endogenous peptides generated by the class I antigen processing pathway.

Yamashita Y, Anczurowski M, Nakatsugawa M, Tanaka M, Kagoya Y, Sinha A, Chamoto K, Ochi T, Guo T, Saso K, Butler MO, Minden MD, Kislinger T, Hirano N.

Nat Commun. 2017 May 10;8:15244. doi: 10.1038/ncomms15244.

13.

Correction: Key Residues at Third CDR3β Position Impact Structure and Antigen Recognition of Human Invariant NK TCRs.

Chamoto K, Guo T, Scally SW, Kagoya Y, Anczurowski M, Wang CH, Rahman MA, Saso K, Butler MO, Chiu PPL, Julien JP, Hirano N.

J Immunol. 2017 May 1;198(9):3757. doi: 10.4049/jimmunol.1700296. No abstract available.

14.

Transient stimulation expands superior antitumor T cells for adoptive therapy.

Kagoya Y, Nakatsugawa M, Ochi T, Cen Y, Guo T, Anczurowski M, Saso K, Butler MO, Hirano N.

JCI Insight. 2017 Jan 26;2(2):e89580. doi: 10.1172/jci.insight.89580.

15.

[A Case of Metachronous Liver Metastases of Gall Bladder Cancer Successfully Treated by Liver Resection].

Asai K, Murata M, Saso K, Yamada M, Sawami H, Suzuki R, Fukunaga H, Tanaka N, Yamamoto M, Hiratsuka M.

Gan To Kagaku Ryoho. 2016 Nov;43(12):2092-2094. Japanese.

PMID:
28133232
16.

Key Residues at Third CDR3β Position Impact Structure and Antigen Recognition of Human Invariant NK TCRs.

Chamoto K, Guo T, Scally SW, Kagoya Y, Anczurowski M, Wang CH, Rahman MA, Saso K, Butler MO, Chiu PP, Julien JP, Hirano N.

J Immunol. 2017 Feb 1;198(3):1056-1065. doi: 10.4049/jimmunol.1601556. Epub 2016 Dec 21. Erratum in: J Immunol. 2017 May 1;198(9):3757.

17.

Generating De Novo Antigen-specific Human T Cell Receptors by Retroviral Transduction of Centric Hemichain.

Guo T, Ochi T, Nakatsugawa M, Kagoya Y, Anczurowski M, Wang CH, Rahman MA, Saso K, Butler MO, Hirano N.

J Vis Exp. 2016 Oct 25;(116). doi: 10.3791/54697.

18.

BET bromodomain inhibition enhances T cell persistence and function in adoptive immunotherapy models.

Kagoya Y, Nakatsugawa M, Yamashita Y, Ochi T, Guo T, Anczurowski M, Saso K, Butler MO, Arrowsmith CH, Hirano N.

J Clin Invest. 2016 Sep 1;126(9):3479-94. doi: 10.1172/JCI86437. Epub 2016 Aug 22.

19.

CD4(+) and CD8(+) TCRβ repertoires possess different potentials to generate extraordinarily high-avidity T cells.

Nakatsugawa M, Rahman MA, Yamashita Y, Ochi T, Wnuk P, Tanaka S, Chamoto K, Kagoya Y, Saso K, Guo T, Anczurowski M, Butler MO, Hirano N.

Sci Rep. 2016 Mar 31;6:23821. doi: 10.1038/srep23821.

20.

The Histone Variant MacroH2A1.2 Is Necessary for the Activation of Muscle Enhancers and Recruitment of the Transcription Factor Pbx1.

Dell'Orso S, Wang AH, Shih HY, Saso K, Berghella L, Gutierrez-Cruz G, Ladurner AG, O'Shea JJ, Sartorelli V, Zare H.

Cell Rep. 2016 Feb 9;14(5):1156-1168. doi: 10.1016/j.celrep.2015.12.103. Epub 2016 Jan 28.

21.

[A Case of Recurrence of Rectal Cancer with Para-Aortic Lymph Node Metastases Successfully Resected Resulting in Long Term Survival].

Sawami H, Murata M, Takahashi H, Tanaka N, Asai K, Saso K, Yagi T, Yamada M, Katsuyama S, Takayama O, Baba M, Yamamoto M, Hiratsuka M.

Gan To Kagaku Ryoho. 2015 Nov;42(12):2310-2. Japanese.

PMID:
26805347
22.

[A Case of Unresectable Rectal Cancer Associated with Hemorrhage of the Primary Tumor after Chemotherapy].

Yamada M, Takahashi H, Murata M, Tanaka N, Asai K, Saso K, Yagi T, Katsuyama S, Sawami H, Takayama O, Baba M, Yamamoto M, Hiratsuka M.

Gan To Kagaku Ryoho. 2015 Nov;42(12):1659-61. Japanese.

PMID:
26805129
23.

[A Case of Pancreatic Cancer with Multiple Liver Metastases That Developed Postoperatively and Showed a Complete Response with S-1 Monotherapy].

Saso K, Murata M, Asai K, Yamada M, Yagi T, Katsuyama S, Sawami H, Takahashi H, Takayama O, Tanaka N, Baba M, Yamamoto M, Hiratsuka M.

Gan To Kagaku Ryoho. 2015 Nov;42(12):1620-2. Japanese.

PMID:
26805116
24.

[A Case of Gastric Cancer with Multiple Liver Metastases Treated with XP Chemotherapy and RFA Resulting in a Complete Response for a Long Time].

Katsuyama S, Murata M, Tanaka N, Asai K, Saso K, Yamada M, Yagi T, Sawami H, Takahashi H, Takayama O, Baba M, Yamamoto M, Hiratsuka M.

Gan To Kagaku Ryoho. 2015 Nov;42(12):1614-6. Japanese.

PMID:
26805114
25.

[A case of colon cancer with multiple liver metastases showing a long-term response following first-line therapy].

Sawami H, Murata M, Takahashi H, Tanaka N, Asai K, Saso K, Yagi T, Yamada M, Katsuyama S, Takayama O, Baba M, Yamamoto M, Hiratsuka M.

Gan To Kagaku Ryoho. 2014 Nov;41(12):1704-6. Japanese.

PMID:
25731302
26.

[A case of locally advanced rectal carcinoma treated with preoperative chemoradiotherapy resulting in pathologically complete response].

Katsuyama S, Murata M, Tanaka N, Asai K, Saso K, Yagi T, Yamada M, Sawami H, Takahashi H, Takayama O, Baba M, Kondo S, Son M, Kimura H, Fukuda H, Yamamoto M, Hiratsuka M.

Gan To Kagaku Ryoho. 2014 Nov;41(12):1563-5. Japanese.

PMID:
25731253
27.

Histone demethylase JMJD2B functions as a co-factor of estrogen receptor in breast cancer proliferation and mammary gland development.

Kawazu M, Saso K, Tong KI, McQuire T, Goto K, Son DO, Wakeham A, Miyagishi M, Mak TW, Okada H.

PLoS One. 2011 Mar 18;6(3):e17830. doi: 10.1371/journal.pone.0017830.

28.

Defective FESTA/EAF2-mediated transcriptional activation in S-II-deficient embryonic stem cells.

Ito T, Saso K, Arimitsu N, Sekimizu K.

Biochem Biophys Res Commun. 2007 Nov 23;363(3):603-9. Epub 2007 Sep 14.

PMID:
17892859
29.

Transcription elongation factor S-II is required for definitive hematopoiesis.

Ito T, Arimitsu N, Takeuchi M, Kawamura N, Nagata M, Saso K, Akimitsu N, Hamamoto H, Natori S, Miyajima A, Sekimizu K.

Mol Cell Biol. 2006 Apr;26(8):3194-203.

30.

A dwarf mutant strain of Pharbitis nil, Uzukobito (kobito), has defective brassinosteroid biosynthesis.

Suzuki Y, Saso K, Fujioka S, Yoshida S, Nitasaka E, Nagata S, Nagasawa H, Takatsuto S, Yamaguchi I.

Plant J. 2003 Nov;36(3):401-10.

31.

Cytogenetic studies of Hynobiidae (Urodela)XVIII. A ZZ/ZW sex-determining mechanism in a hynobiid salamander species, Hynobius tokyoensis Tago.

Kuro-o M, Ikebe C, Izumisawa Y, Fujinuki Y, Sasaki K, Saso K, Akaba K, Kohno S.

Cytogenet Genome Res. 2002;99(1-4):194-9.

PMID:
12900564
33.

Th1/Th2 cytokine profiles and their relationship to clinical features in patients with chronic hepatitis C virus infection.

Sobue S, Nomura T, Ishikawa T, Ito S, Saso K, Ohara H, Joh T, Itoh M, Kakumu S.

J Gastroenterol. 2001 Aug;36(8):544-51.

PMID:
11519833
34.

Percutaneous radiofrequency ablation therapy using a clustered electrode in the animal liver.

Horigome H, Nomura T, Saso K, Fujino N, Murasaki G, Kato Y, Kanematsu T, Joh T, Ohara H, Hashimoto T, Suzuki T, Itoh M.

Hepatogastroenterology. 2001 Jan-Feb;48(37):163-5.

PMID:
11268956
35.

Diagnosis of small hepatocellular carcinoma--imaging diagnosis and significance of tumor biopsy.

Horigome H, Nomura T, Saso K, Joh T, Ohara H, Akita S, Sobue S, Mizuno Y, Kato Y, Kanematsu T, Murasaki G, Itoh M.

Hepatogastroenterology. 2000 Nov-Dec;47(36):1659-62.

PMID:
11149027
36.

Artificial ascites method: percutaneous treatments for hepatocellular carcinoma located just beneath the diaphragm.

Horigome H, Nomura T, Saso K, Joh T, Ohara H, Itoh M.

Am J Gastroenterol. 2000 Sep;95(9):2404-5. No abstract available.

PMID:
11007266
37.

Treatment of solitary small hepatocellular carcinoma: consideration of hepatic functional reserve and mode of recurrence.

Horigome H, Nomura T, Nakao H, Saso K, Takahashi Y, Akita S, Sobue S, Mizuno Y, Nojiri S, Hirose A, Masuko K, Murasaki G, Fujino N, Nakahara R, Ichikawa T, Itoh M.

Hepatogastroenterology. 2000 Mar-Apr;47(32):507-11.

PMID:
10791223
38.

Coexistence of primary biliary cirrhosis and myasthenia gravis: a case study.

Horigome H, Nomura T, Saso K, Joh T, Ohara H, Akita S, Sobue S, Mizuno Y, Kato Y, Itoh M.

Hepatogastroenterology. 2000 Jan-Feb;47(31):125-7.

PMID:
10690593
39.

Endoscopic injection sclerotherapy for esophagogastric variceal bleeding in children with biliary atresia.

Horigome H, Nomura T, Saso K, Hashimoto T, Suzuki T, Joh T, Ohara H, Akita S, Sobue S, Mizuno Y, Kato Y, Ohmi H, Itoh M.

Hepatogastroenterology. 1999 Nov-Dec;46(30):3060-2.

PMID:
10626160
41.

Limitations of imaging diagnosis for small hepatocellular carcinoma: comparison with histological findings.

Horigome H, Nomura T, Saso K, Itoh M, Joh T, Ohara H.

J Gastroenterol Hepatol. 1999 Jun;14(6):559-65.

PMID:
10385065
42.

Differential inhibition of epidermal growth factor signaling pathways in rat hepatocytes by long-term ethanol treatment.

Saso K, Moehren G, Higashi K, Hoek JB.

Gastroenterology. 1997 Jun;112(6):2073-88.

PMID:
9178701
43.

Inhibitory effect of ethanol on hepatocyte growth factor-induced DNA synthesis and Ca2+ mobilization in rat hepatocytes.

Saso K, Higashi K, Nomura T, Hoshino M, Ito M, Moehren G, Hoek JB.

Alcohol Clin Exp Res. 1996 Dec;20(9 Suppl):330A-334A.

PMID:
8986232
44.

Effect of glutathione on inositol 1,4,5-triphosphate-induced Ca2+ release in permeabilized hepatocytes from control and chronic ethanol-fed rats.

Nomura T, Higashi K, Hoshino M, Saso K, Itou M, Hoek JB.

Alcohol Clin Exp Res. 1996 Dec;20(9 Suppl):325A-329A.

PMID:
8986231
45.

Interaction of protein phosphatases and ethanol on phospholipase C-mediated intracellular signal transduction processes in rat hepatocytes: role of protein kinase A.

Higashi K, Hoshino M, Nomura T, Saso K, Ito M, Hoek JB.

Alcohol Clin Exp Res. 1996 Dec;20(9 Suppl):320A-324A.

PMID:
8986230
46.

Transfer index of MR relaxation enhancer: a quantitative evaluation of MR contrast enhancement.

Kaneoke Y, Furuse M, Yoshida K, Saso K, Ichihara K, Motegi Y.

AJNR Am J Neuroradiol. 1989 Mar-Apr;10(2):329-33.

PMID:
2494852
47.

Assessment of T1 time course changes and tissue-blood ratios after Gd-DTPA administration in brain tumors.

Yoshida K, Furuse M, Kaneoke Y, Saso K, Inao S, Motegi Y, Ichihara K, Izawa A.

Magn Reson Imaging. 1989 Jan-Feb;7(1):9-15.

PMID:
2918823
48.

[Significance of focal relaxation times in head injury].

Inao S, Furuse M, Saso K, Yoshida K, Motegi Y, Kaneoke Y, Izawa A.

Neurol Med Chir (Tokyo). 1987 Nov;27(11):1039-45. Japanese. No abstract available.

49.

[Evaluation of peritumoral edema by proton T1 values with special remarks on time courses following intracranial surgery].

Yoshida K, Inao S, Saso K, Motegi Y, Kaneoke Y, Furuse M.

No Shinkei Geka. 1987 Apr;15(4):389-95. Japanese.

PMID:
3614531
50.

Spin-lattice relaxation times of bound water--its determination and implications for tissue discrimination.

Kaneoke Y, Furuse M, Inao S, Saso K, Yoshida K, Motegi Y, Mizuno M, Izawa A.

Magn Reson Imaging. 1987;5(6):415-20.

PMID:
3431351

Supplemental Content

Support Center